InvestorsHub Logo

RandolRocketman

07/24/16 9:27 PM

#9369 RE: bettyfordallstar #9368

Since we know L'oreal, are in business with Organovo already with skin tissue samples, that might end up being next in the revenue stream, not sure about bone tissue yet... Seems like a decent revenue stream could be there.
Right so first was liver samples, then kidney samples. Then, who knows, cartridge seems like it would lend itself to 3D printing as well as bone tissue.
Anyway, as soon as they start doing clinical trials for replacement tissue therapy, it will be like it is now with the testing samples. Boom boom boom one after another.

This is the kind of thing that makes engineers salivate, no pun intended.